The Prescription Drug Monitoring Act of 2024 requires states that receive federal funding for prescription drug monitoring programs to implement stronger safeguards against prescription drug misuse. Starting one year after enactment, these states must require doctors and their authorized staff to check their state's monitoring program before prescribing controlled substances in schedules II through IV and every three months during treatment, while pharmacies must report all controlled substance dispensing within 24 hours. The law also mandates that monitoring programs provide proactive alerts to prescribers when misuse patterns are detected, share de-identified data publicly for research and health planning purposes, and report problematic prescribing patterns to law enforcement and licensing boards. States that fail to comply with these requirements risk losing federal grant funding under the Harold Rogers Prescription Drug Monitoring Program and other federal drug monitoring initiatives. This legislation affects all states receiving federal monitoring program funds, healthcare providers, pharmacies, and law enforcement agencies working to combat prescription drug abuse.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.